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The molecular mechanisms that promote excitatory
synapse development have been extensively stud-
ied. However, the molecular events preventing pre-
cocious excitatory synapse development so that
synapses form at the correct time and place are
less well understood. Here, we report the functional
characterization of ARHGAP12, a previously unchar-
acterized Rho GTPase-activating protein (RhoGAP)
in the brain. ARHGAP12 is specifically expressed in
the CA1 region of the hippocampus, where it local-
izes to the postsynaptic compartment of excitatory
synapses. ARHGAP12 negatively controls spine
size via its RhoGAP activity and promotes, by inter-
acting with CIP4, postsynaptic AMPA receptor endo-
cytosis. Arhgap12 knockdown results in precocious
maturation of excitatory synapses, as indicated by
a reduction in the proportion of silent synapses.
Collectively, our data show that ARHGAP12 is a syn-
aptic RhoGAP that regulates excitatory synaptic
structure and function during development.
INTRODUCTION
The dynamic process of formation and fine-tuning of synaptic
connections between neurons is critical for neuronal develop-
ment and proper brain function (Li and Sheng, 2003; McAllister,
2007). Most excitatory synapses are located on dendritic spines,
small filamentous actin (F-actin)-enriched protrusions on den-
drites (Hotulainen and Hoogenraad, 2010). Synaptic efficiency
is rapidly modified during development or in response to
changes in activity by remodeling of spine structure and traf-Cell Rficking of glutamate ionotropic alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptors (AMPARs; Chater
and Goda, 2014).
Several observations have shown that the number of
AMPARs and the geometry of dendritic spines are tightly corre-
lated (Engert and Bonhoeffer, 1999; Kopec and Malinow, 2006;
Matsuzaki et al., 2004). Actin remodeling, which occurs in den-
dritic spines, drives changes in spine morphology and is
required, but not sufficient, for stable long-term potentiation
(LTP), one of the core mechanisms of synaptic plasticity under-
lying learning and memory (Cingolani and Goda, 2008; Malinow
and Malenka, 2002). Inhibition of spine enlargement by block-
ing actin polymerization prevents proper LTP expression (Fuka-
zawa et al., 2003; Ramachandran and Frey, 2009), whereas
increasing spine size alone, by promoting actin polymerization,
is not sufficient to express LTP (Cingolani and Goda, 2008;
Okamoto et al., 2004; Wang et al., 2007). Evidence suggests
that impairments in spine structure and synaptic strength dur-
ing development contribute to numerous neurological diseases,
including intellectual disability (ID), autism spectrum disorder
(ASD), and schizophrenia (Nadif Kasri and Van Aelst, 2008;
Penzes et al., 2011; Phillips and Pozzo-Miller, 2015; Xu et al.,
2014).
Howmodifications in spine structure and synaptic strength are
coordinated, however, remains largely unknown. As key regula-
tors of the actin cytoskeleton, the Rho subfamily members of
guanosine triphosphate (GTP)-binding proteins play a critical
role in synapse formation, maturation, and maintenance, directly
affecting both synapse structure and function (Ba et al., 2013;
Nadif Kasri and Van Aelst, 2008; Tolias et al., 2011). Members
of the Rho subfamily of GTP-binding proteins act as molecular
switches cycling between an active GTP-bound form and an
inactive guanosine diphosphate-bound form. Their activity is
mainly regulated by guanine nucleotide exchange factors
(GEFs), which are positive regulators, and by guanosineeports 14, 1355–1368, February 16, 2016 ª2016 The Authors 1355
triphosphatase (GTPase)-activating proteins (GAPs) and gua-
nine nucleotide dissociated inhibitors, which are negative regu-
lators (Van Aelst and D’Souza-Schorey, 1997). GEFs and GAPs
are typically multi-domain proteins, and their expression levels
are tightly regulated during development. Their specific spatial
and temporal expression patterns enable them to regulate syn-
aptic function through the interaction with diverse upstreammol-
ecules and downstream effectors (Tolias et al., 2011). Several
Rho GEFs and GAPs have been shown to uniquely regulate syn-
aptic development and plasticity (Duman et al., 2015; Guerrier
et al., 2009; Ip et al., 2012). In addition, a number of Rho GTPase
regulators and effectors have been directly associated with ID,
including Oligophrenin-1 (Nadif Kasri et al., 2009, 2011),
OCRL1 (Hichri et al., 2011), ARHGEF6 (Kutsche et al., 2000),
and PAK3 (Allen et al., 1998). However, remarkably little is known
about how individual GEFs or GAPs precisely coordinate synap-
tic morphology and function during development.
In this study, we focused on ARHGAP12, a RhoGAP that nega-
tively regulates Rac1 signaling and whose function has not yet
been described in the brain. We found that ARHGAP12 is almost
exclusively expressed in hippocampal CA1 neurons during early
stages of development. We investigated the postsynaptic func-
tion of ARHGAP12 by spatially and temporally manipulating the
levels of ARHGAP12, specifically at hippocampal CA3-CA1 syn-
apses. We characterized ARHGAP12 as a structure-function
coordinator of excitatory synapses during hippocampal devel-
opment. Our results uncover a dual function for ARHGAP12 in
coordinating synaptic structure and AMPAR trafficking in hippo-
campal CA3-CA1 synapses during development.
RESULTS
Expression and Distribution of ARHGAP12 in the
Hippocampus
To identify Rho GTPase regulators that are critical for the devel-
opment of cell-type-specific synapses in the hippocampus, we
used the mRNA expression data from the Allen Brain Atlas
(http://mouse.brain-map.org/). We focused on Rho GTPase reg-
ulators with a specific spatial expression pattern. We identified
the Rac1 GAP protein, ARHGAP12 (Gentile et al., 2008), as an
interesting candidate protein based on its specific CA1 and, to
a lesser extent, dentate gyrus (DG) expression (Figure 1A). We
initiated the characterization of ARHGAP12 by determining its
spatiotemporal distribution in the rat hippocampus. Immuno-
staining experiments revealed that ARHGAP12 was prominently
expressed in the hippocampal CA1 region and to a lesser extent
in the DG, confirming the mRNA expression data. ARHGAP12
was detected in all hippocampal CA1 pyramidal cell layers, in
the somata, and along the dendrites (Figure 1B). We next
examined the expression of ARHGAP12 during different stages
of hippocampal development by western blot. ARHGAP12 was
abundantly expressed in embryonic day 18 (E18) and early
postnatal (1–2 weeks) hippocampus; thereafter, its expression
gradually declined into adulthood. In adult hippocampus, the
expression of ARHGAP12 was still detectable but remarkably
decreased compared to E18 hippocampus (Figure 1C). These
results show that ARHGAP12 is expressed in a distinct spatio-
temporal pattern within the hippocampus.1356 Cell Reports 14, 1355–1368, February 16, 2016 ª2016 The AuthThe subcellular distribution of Rho GEFs and GAPs is instruc-
tive for their function (Govek et al., 2011). We therefore assessed
the subcellular distribution of ARHGAP12 in hippocampal CA1
pyramidal neurons. To this end, we tagged ARHGAP12 at its
N terminus with GFP and introduced GFP-Arhgap12, together
with a red fluorescent protein (dsRed) as a cellular marker, into
CA1 cells in 12 days in vitro (DIV) organotypic hippocampal slices
by biolistic transfection. The partition of ARHGAP12 between
spines and dendrites was calculated from the ratio of the GFP
and dsRed signal in the spine head versus the adjacent dendritic
shaft (Nadif Kasri et al., 2009). We found a strong enrichment of
ARHGAP12 in the spines compared to the dendrites (Figure 1D).
Consistently, we observed overlapping localization of endoge-
nous ARHGAP12 with postsynaptic density-95 (PSD95) in the
stratum radiatum of the hippocampal CA1 region (Figure 1E).
Finally, we showed that ectopically expressed GFP-ARHGAP12
colocalized with PSD95 and was found juxtaposed to the pre-
synaptic marker Synapsin-1 in hippocampal primary neurons
(Figure S1). Together, these data reveal that ARHGAP12 is
located postsynaptically in excitatory synapses of hippocampal
CA1 pyramidal neurons.
Negative Regulation of SpineMorphology by ARHGAP12
Given the presence of ARHGAP12 in spines, and the importance
of Rho GTPases in controlling actin cytoskeleton remodeling, we
first examined the role of ARHGAP12 in regulating dendritic
spine morphology in CA1 pyramidal neurons. We biolistically
introduced a GFP-expressing construct, as a cellular marker,
with or without a second construct containing Arhgap12 into
CA1 neurons in organotypic hippocampal slices. Immunostain-
ing experiments revealed that neurons transfected with
GFP alone showed ARHGAP12 levels similar to those of adja-
cent non-transfected neurons, whereas neurons expressing
Arhgap12 exhibited a 10-fold increase in ARHGAP12 levels
(Figure S2B). Compared to neurons expressing GFP alone,
Arhgap12-overexpressing CA1 pyramidal neurons displayed a
significant decrease in both spine density and volume (spine
density—GFP control: 5.02 ± 0.22 spines/10 mm, Arhgap12:
1.87 ± 0.44 spines/10 mm; spine volume—GFP control:
270.56 ± 49.22 a.u., Arhgap12: 153.03 ± 52.68 a.u.; Figures
2A–2C). In addition, we found that elevated ARHGAP12 levels
significantly increased the percentage of immature spines in
CA1 neurons (GFP control: 6.03% ± 1.05%; Arhgap12:
15.90% ± 3.45%; Figure 2D). These observations are consistent
with experiments in which reduced Rac1 activity has been
coupled to reduced spine density and size (Haditsch et al., 2009).
We next examined the function of endogenous ARHGAP12 by
probing the effects of reduced ARHGAP12 expression on den-
dritic spines. Constructs were generated to co-express GFP
and short hairpin RNAs (shRNAs) targeting either the 30 UTR
(Arhgap12 sh#1) or the translated region (Arhgap12 sh#2) of rat
Arhgap12 mRNA. Arhgap12 shRNAs significantly reduced
endogenous ARHGAP12 protein levels in hippocampal primary
neurons (Figure S2A), as well as in organotypic hippocampal
slices (Figure S2B). We found that neither shRNA (Arhgap12
sh#1 and #2) affected spine density (GFP control: 5.02 ± 0.22
spines/10 mm; Arhgap12 sh#1: 5.06 ± 0.62 spines/10 mm;
Arhgap12 sh#2: 5.02 ± 1.41 spines/10 mm), but both significantlyors
Figure 1. Expression and Distribution of ARHGAP12 in the Hippocampus
(A) In situ hybridization of Arhgap12 from the Allen Brain Atlas database. Scale bars, 50 mm.
(B) Hippocampi sections from a P20 rat double-immunolabeled with an anti-ARHGAP12 antibody (red) and an anti-NeuN antibody (green). Scale bars, 50 mm.
(C1) Rat hippocampi collected at indicated ages and probedwith anti-ARHGAP12 antibody. Expression of g-tubulin was used as a loading control; equal amounts
of protein (50 mg) were loaded.
(C2) Quantification of ARHGAP12 proteins levels at indicated postnatal ages. ARHGAP12 expression was normalized to g-tubulin in the same sample. Data are
shown as mean ± SEM; n = 3.
(D1) Left: representative images of a dendritic branch of a hippocampal CA1 pyramidal neuron co-transfected with GFP-Arhgap12 (green) and dsRed (red). Right:
ratio image of the representative cell. Blue depicts low ARHGAP12 enrichment, and red depicts high density. Scale bar, 5 mm.
(D2) Quantification of GFP-ARHGAP12 enrichment in spines. Data are shown as mean ± SEM; n = 8; **p < 0.01, t test.
(E) Left: hippocampi sections from a P20 rat double-immunolabeled with an anti-ARHGAP12 antibody (green) and an anti-PSD95 antibody (red). Right: higher
magnification images of the area indicated in the white box on the left panel. White arrows indicate sites of co-localization of ARHGAP12 and PSD95. Scale
bars, 10 mm.
See also Figure S1.increased spine volume (GFP control: 270.56 ± 49.22 a.u.;
Arhgap12 sh#1: 443.69 ± 52.30 a.u.; Arhgap12 sh#2: 416.79 ±
116.03 a.u.; Figures 2B and 2C). The percentage of immature
spines also significantly decreased in neurons expressing
Arhgap12 shRNAs (GFP control: 6.03% ± 1.05%; Arhgap12Cell Rsh#1: 1.33% ± 1.34%; Arhgap12 sh#2: 1.68% ± 1.42%;
Figure 2D). We were able to rescue these phenotypes by co-ex-
pressing Arhgap12 sh#1 with an Arhgap12-expressing vector
that lacked the 30 UTR and was therefore resistant to Arhgap12
sh#1-mediated knockdown. This confirmed that the knockdowneports 14, 1355–1368, February 16, 2016 ª2016 The Authors 1357
Figure 2. ARHGAP12 Negatively Regulates
Spine Morphology
(A) Representative images of secondary apical
dendrites from CA1 neurons transfected with
indicated constructs. Scale bars, 10 mm.
(B–D) Quantification of spine density (B), spine
volume (C), and percentage of immature spines (D)
for indicated experimental conditions. Data are
shown as mean ± SEM; GFP: n = 15, Arhgap12:
n = 9, Arhgap12 sh#1: n = 8, Arhgap12 sh#2: n = 7,
Arhgap12 sh#1 + Arhgap12: n = 9; data from three
to four independent experiments. A minimum of
500 spines were analyzed per condition; *p < 0.05,
**p < 0.01, one-way ANOVA.
See also Figures S2 and S3.effects were mediated specifically by loss of ARHGAP12 (spine
density—GFP control: 5.02 ± 0.22 spines/10 mm, Arhgap12
sh#1 + Arhgap12: 4.77 ± 1.02 spines/10 mm; spine volume—
GFP control: 270.56 ± 49.22 a.u., Arhgap12 sh#1 + Arhgap12:
226.51 ± 103.55 a.u.; Figures 2B–2D). Immunostaining experi-
ments on biolistically transfected organotypic hippocampal
slices confirmed that the levels of ARHGAP12 were restored to
normal levels (Figure S2B).
Next, we examined whether the regulation of ARHGAP12 on
spine morphology was dependent on activity. To this end, we
treated organotypic slices with a high concentration of MgCl2
or the N-methyl-D-aspartate receptor (NMDAR) antagonist
2-amino-5-phosphonovaleric acid (APV, 100 mM) on the same
day of biolistic transfection. Both manipulations, however, did
not prevent the enlargement of spine volume induced by
Arhgap12 downregulation (Figure S3A), indicating that knocking
down Arhgap12 is sufficient to increase spine size. Because the
expression of ARHGAP12 declines during normal development,
wewonderedwhether blocking NMDARactivity would affect this
process. We found that the gradual decrease of ARHGAP12
levels did not occur in the presence of APV (Figure S3C),
suggesting that the developmental elimination of ARHGAP12 is
dependent on NMDAR activity.
Together, our results support a model in which NMDAR
activity during development drives the repression of ARHGAP12,
resulting in the enlargement of spines.
Selective Modulation of Synaptic AMPAR-Mediated
Transmission by ARHGAP12
Because of the importance of dendritic spine structure for
synaptic function and the effects of ARHGAP12 on spine
morphology, we next assessed the role of ARHGAP12 in
modulating excitatory synaptic function. We first examined the
effects of ARHGAP12 overexpression on synaptic transmission.
Simultaneous whole-cell recordings of evoked excitatory
postsynaptic currents (EPSCs) were recorded at 7 DIV from
CA1 pyramidal neurons expressing GFP-Arhgap12 and
from adjacent non-transfected neurons. Overexpression of
Arhgap12 significantly depressed AMPAR- and NMDAR-
mediated synaptic transmission (AMPAR-EPSC—uninfected:
197.61 ± 21.15 pA, infected: 45.33 ± 4.67 pA; NMDAR-
EPSC—uninfected: 193.71 ± 19.13 pA, infected: 157.84 ±
18.71 pA; Figures 3A and 3D), suggesting that ectopically ex-1358 Cell Reports 14, 1355–1368, February 16, 2016 ª2016 The Authpressed Arhgap12 is sufficient to depress AMPAR- and
NMDAR-mediated transmission. Overexpression of GFP alone
did not alter AMPAR- or NMDAR-mediated synaptic transmis-
sion (Figure S4A). These observations complement our finding
that ectopic expression of Arhgap12 significantly reduced the
number of mature spines and therefore could explain the
changes in NMDAR-EPSCs, in addition to the changes in
AMPAR-EPSCs.
Next, we examined the effects of ARHGAP12 downregulation
in regulating synaptic transmission. We found that down-
regulation of ARHGAP12 levels resulted in potentiation of
AMPAR-mediated transmission but not NMDAR-mediated
transmission (Arhgap12 sh#1—AMPAR-EPSC uninfected:
40.03 ± 8.98 pA, AMPAR-EPSC infected: 60.57 ± 7.85 pA,
NMDAR-EPSC uninfected: 67.28 ± 7.40 pA, NMDAR-EPSC in-
fected: 72.82 ± 9.94 pA; Arhgap12 sh#2—AMPAR-EPSC unin-
fected: 51.32 ± 8.03 pA, AMPAR-EPSC infected: 70.91 ±
5.43 pA, NMDAR-EPSC uninfected: 62.13 ± 8.85 pA, NMDAR-
EPSC infected: 67.88 ± 10.62 pA; Figures 3B–3D), indicating
that downregulation of ARHGAP12 is sufficient to enhance
AMPAR-mediated transmission. These results are consistent
with our observation that reducing endogenous ARHGAP12
results in larger dendritic spines without affecting the spine
density. Thus, bidirectional manipulation of ARHGAP12 levels
is associated with opposing effects toward AMPAR-mediated
synaptic transmission.
To test whether the effect of ARHGAP12 on AMPARs is
restricted to synaptic AMPARs, we recorded extrasynaptic
responses evoked by bath application of AMPA (1 mM), which
initiated inward currents in all neurons (Arendt et al., 2010). No
differences in AMPA-induced inward currents were observed
between control uninfected neurons and Arhgap12 sh#1 in-
fected neurons (Figure 3E), indicating that the modulation of
glutamatergic receptors by ARHGAP12 is specific for synaptic
AMPARs. Because altered AMPAR-mediated EPSC may also
result from an altered proportion of GluA2-lacking AMPARs,
whose currents show unique inward rectification, we further
measured the rectification index of AMPAR-EPSCs by
measuring AMPAR-mediated EPSCs at 60 and at +40 mV
holding potential, in the presence of intracellular spermine
(Bowie and Mayer, 1995). However, we did not observe a
significant difference between uninfected neurons and
Arhgap12 sh#1 infected neurons (Figure 3F), indicating thators
Figure 3. Postsynaptic ARHGAP12 Modulates AMPAR-Mediated Transmission
(A–C) Amplitudes of AMPAR-EPSCs (left panels) and NMDAR-EPSCs (right panels) of uninfected neurons are plotted against simultaneously recorded neigh-
boring neurons expressing Arhgap12 (A), Arhgap12 sh#1 (B), and Arhgap12 sh#2 (C). Recordings were performed at 7 DIV. Black symbols represent single pairs
of recordings; green or gray symbols show mean values. Inserts in each panel show sample average traces: black traces, uninfected neurons; gray traces,
Arhgap12-overexpressed neurons; green traces, Arhgap12 shRNAs expressing neurons. Scale bars, 10 ms and 25 pA.
(D) Summary of effects of Arhgap12 overexpression or knockdown. Data are shown as mean ± SEM; n = 9–15 from three independent experiments; *p < 0.05,
paired t test.
(E) Time course of whole-cell currents recorded from CA1 pyramidal neurons infected with Arhgap12 sh#1 or control uninfected neurons during the application of
1 mM AMPA. Uninfected: n = 9, Arhgap12 sh#1: n = 8; data from two independent experiments.
(F) Synaptic responses were recorded at 60 and +40 mV from CA1 pyramidal neurons infected with Arhgap12 sh#1 or uninfected neurons in the presence of
intracellular spermine. The rectification index was calculated by dividing the amplitude at60 mV by the amplitude at +40 mV. n = 8 for both conditions from two
independent experiments.
(G) Representative traces and quantifications of excitatory miniature events recorded from uninfected neurons and neurons expressing Arhgap12 sh#1 at 7 DIV.
Scale bars, 1 s and 25 pA. Data are shown as mean ± SEM; n = 13–15 from three independent experiments; *p < 0.05, t test.
(H) Paired-pulse facilitation (EPSC2/EPSC1) recorded from uninfected and Arhgap12 sh#1-expressing neurons at indicated inter-stimulus intervals. Data are
shown as mean ± SEM; n = 7 for both groups from three independent experiments.
See also Figure S4.
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Figure 4. Arhgap12 Knockdown Promotes
Hippocampal Synaptic Development by
Accelerating Silent Synapse Unsilencing
(A) Minimal stimulation assay. Representative plot
of individual responses at 60 and +40 mV with
minimal stimulations in indicated conditions.
(B) Failures of responses using minimal stimulation
at 60 and +40 mV from uninfected neurons and
Arhgap12 sh#1 infected neurons.
(C) Percentage of silent synapses at different
developmental stages of uninfected neurons and
Arhgap12 sh#1 infected neurons. Data are shown
asmean ± SEM; n = 11–14 from three independent
experiments; *p < 0.05, paired t test.
(D) Evoked AMPAR-mediated transmission re-
corded from CA1 pyramidal neurons infected with
Arhgap12 sh#1 and uninfected neurons at different
developmental stages. Data are shown as mean ±
SEM; n = 11–15 for both groups at all time points,
from three to four independent experiments; *p <
0.05, paired t test.
See also Figure S5.enhanced AMPAR-EPSCs were not a result of changes in
AMPAR subunit composition.
The changes in AMPAR-mediated transmission could result
from a change of synaptic AMPARs at individual synapses, a
change in the number of functional synapses, or both. To
determine the precise mechanism, we measured the effect of
ARHGAP12 on the amplitudes and frequencies of miniature
excitatory postsynaptic currents (mEPSCs). Arhgap12 sh#1
largely increased both frequency and amplitude of mEPSCs in
CA1 pyramidal neurons (Figure 3G). The change in amplitude
supports our previous findings showing that ARHGAP12 affects
synaptic AMPAR function. A change in frequency usually reflects
a change in the number of active synapses or in the presynaptic
release probability. We further examined presynaptic release by
measuring the paired-pulse ratio. We did not observe significant
differences between uninfected and Arhgap12 sh#1-expressing
neurons (Figure 3H), indicating that no retrograde signaling was
involved to alter presynaptic release probability and the changes
in frequency reflect a change in the amount of active synapses.
Finally, we evaluated the impact of ARHGAP12 on inhibitory
(GABAergic) synaptic function in CA1 pyramidal neurons.
Evoked inhibitory postsynaptic currents (IPSCs) were measured
on neurons expressing Arhgap12 sh#1 and adjacent control un-
infected neurons on hippocampal slices at 7 DIV. We found that
Arhgap12 knockdown did not affect evoked IPSCs (Figure S4B).
Together, our findings indicate that ARHGAP12 is critical for
modulating excitatory, but not inhibitory, synaptic transmission
at the postsynaptic terminal in a cell-autonomous way.
Arhgap12 Knockdown Promotes Hippocampal Synaptic
Development by Accelerating Silent Synapse
Unsilencing
Next, we sought to further delineate the mechanism by which
ARHGAP12 restricts synaptic function. We reasoned that a
plausible mechanism could involve the regulation of silent syn-
apse activation. Silent synapses refer to those synapses with1360 Cell Reports 14, 1355–1368, February 16, 2016 ª2016 The AuthNMDARs but no functional AMPARs (Hanse et al., 2013), and
they can convert to active synapses by AMPAR insertion
(also termed unsilencing) during development and/or in
response to neuronal activity (Isaac et al., 1995; Kerchner
and Nicoll, 2008). In the hippocampus, the proportion of these
silent synapses rapidly decreases during the first 2 weeks of
postnatal development (Kerchner and Nicoll, 2008). To detect
silent synapses, we performed whole-cell patch-clamp record-
ings on CA1 pyramidal neurons using minimum stimulation. In
control uninfected 4 DIV CA1 neurons, the failure rate was
much larger at 60 mV than at +40 mV (Figures 4A and 4B),
indicating that a substantial fraction of the synapses is still
silent at this stage of development (Figure 4C). As expected,
the proportion of silent synapses gradually decreased during
development, with almost all synapses unsilenced at 14 DIV
(Figure 4C). When the same experiments were performed on
Arhgap12 sh#1-expressing hippocampal CA1 neurons, we
found that the proportion of silent synapses was significantly
decreased at the earlier developmental time points (4 and
7–8 DIV) but was comparable to control at 13–14 DIV (Fig-
ure 4C), suggesting that Arhgap12 downregulation promotes
synaptic maturation by accelerating synapse unsilencing.
Robust synaptogenesis occurs during the first 2 weeks of
postnatal development, and a major mechanism underlying
these critical events is synapse unsilencing. Because the
developmental gradient of ARHGAP12 expression is inversely
correlated to the trend of synaptic maturation in hippocam-
pus, we speculated that ARHGAP12 might act as an endoge-
nous ‘‘brake’’ during development. Namely, decreasing levels
of ARHGAP12 would release repression and accelerate syn-
aptogenesis and functional synapse maturation. If this is the
case, the potentiation of CA3-CA1 synapses would be stron-
ger when Arhgap12 is downregulated in the early develop-
mental stages compared to that at the later stages.
Conversely, keeping ARHGAP12 expression at a high level
throughout development would severely limit excitatoryors
Figure 5. Interaction of ARHGAP12
with CIP4
(A) Domain structure of ARHGAP12 and fragments
used as bait in yeast two-hybrid screening. Pres-
ence or absence of positive colonies using distinct
bait was indicated with + or , respectively.
(B and C) CoIP of ARHGAP12 and CIP4 in vitro.
Protein extract fromHEK293T cells co-transfected
with GFP-Arhgap12 and myc-Cip4 constructs
for 24 hr was incubated with mouse immuno-
globulin G or with an anti-Myc antibody (B) or an
anti-ARHGAP12 antibody (C). The immunopre-
cipitates were analyzed by immunoblotting using
indicated antibodies. n = 6.
(D) CoIP of ARHGAP12 mutants and CIP4 in vitro.
Extract from HEK293T cells co-transfected with
myc-Cip4 and indicated mutants of Arhgap12 for
24 hr was incubated with an anti-CIP4 antibody.
Immune complexes were immunoblotted with an
anti-ARHGAP12 antibody. n = 3.synapse development. We first tested this hypothesis by
knocking down Arhgap12 in organotypic hippocampal slices,
and we compared evoked AMPAR-EPSC on a CA1 pyramidal
neuron expressing Arhgap12 sh#1 and an adjacent uninfected
neuron at different stages of the development (4, 7–8, and
13–14 DIV). Whole-cell patch-clamp recordings revealed that
neurons expressing Arhgap12 sh#1 displayed the most pro-
found potentiation of AMPAR-EPSC at 4 DIV and this effect
gradually decreased when recording at later stages, with no
changes observed at 13–14 DIV (Figure 4D). Conversely,
when keeping elevated levels of ARHGAP12 throughout the
development of hippocampal neurons, we observed signifi-
cantly decreased AMPAR-mediated synaptic transmission,
measured as a reduction in amplitude and frequency of
mEPSCs (Figures S5A and S5B). The decreased AMPAR-
mediated transmission was accompanied by a reduction in
PSD95 density, further suggesting that ARHGAP12 can pre-
vent excitatory synapse formation (Figure S5C).
Together, our results indicate that endogenous ARHGAP12
dampens synaptic development by limiting the unsi-
lencing of silent synapses and suggest that endogenous
ARHGAP12 acts as a synaptic brake during hippocampal
development.
Identification of CIP4 as an ARHGAP12 Interactor
Next, to gain insights into the mechanisms by which ARHGAP12
modulates synapses, we sought to identify direct interactors of
ARHGAP12 by performing a GAL4-based interaction trap screen
in yeast (yeast two-hybrid system).
ARHGAP12 contains several protein motifs: a Src homology-3
(SH3) domain at its N terminus, two WW domains, and a Pleck-
strin-homology (PH) domain, followed by a GAP domain shownCell Reports 14, 1355–1368, Fto negatively regulate Rac1 GTPase
(Gentile et al., 2008). Full-length human
ARHGAP12 and fragments containing
different conserved domains were used
as bait in the yeast two-hybrid screening(Figure 5A). Four independent cDNAs matched the sequence
of Cdc42-interacting protein 4 (CIP4, also named thyroid hor-
mone receptor 10 variant; Figure S7A), which harbors a highly
conserved F-BAR (Fes-CIP4 homology-Bin/Amphyphysin/
Rvsp) domain at theN terminus and has recently been implicated
in neurite outgrowth (Saengsawang et al., 2012), clathrin-medi-
ated endocytosis, endosomal trafficking (Itoh and De Camilli,
2006; Shimada et al., 2007; Tsujita et al., 2006), and synaptic
growth at the neuromuscular junction (NMJ) in Drosophila
(Nahm et al., 2010).We subsequently performed co-immunopre-
cipitation (coIP) experiments to validate the interaction between
ARHGAP12 and CIP4. Because none of the antibodies for CIP4
that we have tested to date were suitable for western blot anal-
ysis and IP in vivo (data not shown; Saengsawang et al., 2012),
we co-expressed GFP-Arhgap12 wild-type (WT) and Myc-Cip4
in HEK293T cells and carried out reciprocal coIP experiments
using an anti-Myc and an anti-ARHGAP12 antibody. ARHGAP12
specifically co-immunoprecipitated with CIP4, and vice versa
(Figures 5B and 5C).
Next, we set out to identify the CIP4 binding region in
ARHGAP12. Given that the positive clones from the yeast
two-hybrid screening encompassed the first 156 amino acids
(aa) of ARHGAP12 (Figure 5A), we reasoned that ARHGAP12
is likely to bind to CIP4 via its N-terminal domain. To test this
hypothesis, we generated an ARHGAP12 deletion mutant lack-
ing aa 1–156 (D1–156aa) and repeated the coIP experiment.
We found that the D1–156aa mutant failed to bind CIP4.
Because the first 156 aa of ARHGAP12 include an SH3 domain
and this domain is known to be critical for protein-protein inter-
actions, we reasoned that ARHGAP12 is likely to bind CIP4 via
its SH3 domain. A deletion of the SH3 domain (DSH3) of
ARHGAP12 was generated and tested for its ability to interactebruary 16, 2016 ª2016 The Authors 1361
with full-length CIP4 in HEK293T cells using coIP. Surprisingly,
the DSH3 mutant of ARHGAP12 was still able to bind CIP4,
indicating that the SH3 domain of ARHGAP12 is not required
for interacting with CIP4. Likewise, a point mutation leading
to an inactivation of the GAP function of ARHGAP12 (R695Q;
Figure S6A; Nadif Kasri et al., 2009) did not affect the
ARHGAP12-CIP4 interaction in vitro. Overall, these data indi-
cate that ARHGAP12 can interact with CIP4 via its N-terminal
domain (aa 1–156).
Functional Dissection of ARHGAP12 Controlling
Synaptic Structure and Strength
Previously, ARHGAP12 has been shown to contain a GAP
domain that negatively regulates the activity of Rac1 GTPase
in non-neuronal cells (Gentile et al., 2008). We confirmed that
this is also the case in hippocampal neurons by performing
Rac1 activity assay (Figure S6A).
Because ARHGAP12 also interacts with CIP4 via its N-termi-
nal domain, which has been shown to play a role in clathrin-
mediated endocytosis (Itoh and De Camilli, 2006; Shimada
et al., 2007; Tsujita et al., 2006), we wondered whether these
two distinct domains play separate roles affecting synaptic
structure and function, respectively. As a first step toward
addressing this question, we compared the effects of regulating
dendritic spine morphology between ARHGAP12 WT and two
mutants, Arhgap12_R596Q and Arhgap12_D1–156aa. Spine
structure analysis revealed that expression of the
Arhgap12_R596Q mutant in CA1 pyramidal neurons failed to
mimic the phenotype observed by expressing Arhgap12 WT,
namely, decreased spine density and volume compared to
GFP control (spine density—GFP control: 4.62 ± 0.51 spines/
10 mm, Arhgap12 WT: 2.21 ± 0.82 spines/10 mm, Arh-
gap12_R596Q: 4.17 ± 0.36 spines/10 mm; spine volume—GFP
control: 273.72 ± 57.27 a.u., Arhgap12 WT: 150.11 ± 52.73
a.u., Arhgap12_R596Q: 307.61 ± 35.2 a.u.; Figures 6A and 6B).
Conversely, Arhgap12_D1–156aa-expressing CA1 neurons
displayed spine morphology similar to Arhgap12WT-expressing
neurons (spine density—GFP control: 4.62 ± 0.51 spines/10 mm,
Arhgap12WT: 2.21 ± 0.82 spines/10 mm, Arhgap12_ D1–156aa:
2.41 ± 0.78 spines/10 mm; spine volume—GFP control: 273.72 ±
57.27 a.u., Arhgap12 WT: 150.11 ± 52.73 a.u., Arhgap12_D1–
156aa: 175.45 ± 53.01 a.u.; Figures 6A and 6B). These data indi-
cate that the GAP activity of ARHGAP12, but not its interaction
with CIP4, is required to regulate dendritic spine morphology.
To corroborate our data showing ARHGAP12 affects dendritic
spine structure by acting on the Rac1 signaling pathway, we
examined whether inhibiting Rac1 signaling could rescue the
increased spine volume resulting from Arhgap12 knockdown
by using the competitive inhibitor of Rac1 activation
NSC23766 (Gao et al., 2004). We found that NSC23766
(0.1 mM) treatment of Arhgap12 shRNA transfected hippocam-
pal slices largely rescued the spine volume defects in Arhgap12
knockdown neurons. The mean spine volume did not signifi-
cantly increase compared to control GFP-expressed neurons
(spine density—GFP control: 4.62 ± 0.51 spines/10 mm, Arh-
gap12 sh#1: 5.06 ± 0.62 spines/10 mm, Arhgap12 sh#1 + Rac1
inhibitor: 4.34 ± 0.75 spines/10 mm; spine volume—GFP control:
273.72 ± 57.27 a.u., Arhgap12 sh#1: 443.69 ± 52.30 a.u.,1362 Cell Reports 14, 1355–1368, February 16, 2016 ª2016 The AuthArhgap12 sh#1 + Rac1 inhibitor: 251.54 ± 73.82 a.u.; Figures
6A and 6B). Moreover, we found that, as expected, treating neu-
rons with NSC23766 resulted in decreased spine density and
volume, and this treatment on Arhgap12-overexpressed neu-
rons did not cause additional effects on spine morphology (Fig-
ures S6B and S6C). Overall, these findings imply that the GAP
activity of ARHGAP12, but not ARHGAP12-CIP4 interaction, is
responsible for controlling dendritic spine morphology in CA1
pyramidal neurons via the Rac1 GTPase signaling pathway.
Given that CIP4 is involved in clathrin-dependent endocytosis,
a mechanism that mediates internalization of most plasmamem-
brane proteins, including AMPARs (Man et al., 2000), we specu-
lated that the inhibitory effect of ARHGAP12 on AMPAR function
could be due to involvement of the ARHGAP12-CIP4 complex
in AMPAR endocytosis process. To directly evaluate the
AMPAR endocytotic process, live-cell antibody feeding ex-
periments were performed in 14 DIV primary hippocampal
neurons transfected with GFP, Arhgap12 sh#1, Arhgap12 WT,
Arhgap12_R695Q, or Arhgap12_D1–156aa. We observed
impaired GluA1 endocytosis in neurons expressing Arhgap12
sh#1. Both Arhgap12 WT and Arhgap12_R695Q significantly
enhanced endocytosis of GluA1 compared to the GFP control
condition, whereas theArhgap12_D1–156aamutant did not alter
GluA1 endocytosis (Figure 6C). Functionally, overexpression of
Arhgap12WTdecreased bothmEPSC amplitude and frequency.
Arhgap12_R695Q overexpression led to reducedmEPSC ampli-
tude without affecting frequency, whereas Arhgap12_D1–156aa
resulted in unaltered amplitude but reduced frequency (Figures
6D and 6E).
Furthermore, based on the minimal interacting sequence
(414–428 aa) in CIP4 that we obtained from our yeast two-hybrid
screening (Figure S7A), we designed a small interfering peptide
(PepA12-CIP4) to disrupt the ARHGAP12-CIP4 complex. A corre-
sponding scrambled peptide was used as a control (Pepctrl).
The peptides were conjugated to the cell-membrane transduc-
tion domain of the HIV-1 TAT protein, which allowed the peptide
to cross the membrane of neurons. In HEK293T cells, we found
that PepA12-CIP4 disrupted the ARHGAP12-CIP4 interaction,
whereas Pepctrl did not (Figure 7A). In addition, we observed
no effect of both Pepctrl and PepA12-CIP4 on surface NMDAR
expression and Cdc42-CIP4 interaction (Figures S7B and
S7C). Next, we examined whether disrupting the ARHGAP12-
CIP4 interaction influences GluA1 endocytosis. Live-cell anti-
body feeding experiments were performed in 14 DIV primary
hippocampal neurons treated with Pepctrl or PepA12-CIP4 for
24 hr. Our results showed that PepA12-CIP4 significantly impaired
AMPAR GluA1 subunit endocytosis compared to Pepctrl-treated
neurons (Figure 7B). Electrophysiologically, CA1 pyramidal neu-
rons treated with PepA12-CIP4 exhibited significantly increased
amplitude compared to Pepctrl-treated neurons (Figure 7C).
This indicated that disrupting the interaction of ARHGAP12-
CIP4 was sufficient to increase the amount of AMPARs acc-
umulating at synapses, mimicking the effect of ARHGAP12
knockdown on AMPAR-mediated transmission. Finally, to
further exclude the possibility that the ARHGAP12-CIP4 interac-
tion can regulate spine morphology, we imaged dendritic spine
morphology of neurons treated with Pepctrl or PepA12-CIP4. No
significant differences between the two conditions wereors
Figure 6. ARHGAP12 Regulates Synaptic Structure and Function via Distinct Domains
(A and B) Morphological analysis of dendritic spine density (A) and volume (B) of CA1 pyramidal neurons in indicated conditions. Data are shown as mean ± SEM;
GFP: n = 15, Arhgap12: n = 9, Arhgap12_R695Q: n = 9, Arhgap12_D1–156aa: n = 8, Arhgap12 sh#1 + NSC23766: n = 6; data pooled from three to four inde-
pendent experiments; *p < 0.05, **p < 0.01, one-way ANOVA.
(C) AMPAR endocytosis assay. (C1) Representative double-labeled images of the internalized (green) and surface (red) AMPAR GluA1 subunit in low-density 14
DIV hippocampal neurons in indicated experimental groups. (C2) Ratiometric analysis of the intensity of internalized GluA1 to surface GluA1 in indicated
conditions. Data are shown as mean ± SEM; control: n = 34, Arhgap12 sh#1: n = 20, Arhgap12: n = 15, Arhgap12_R695Q: n = 15, Arhgap12_D1–156aa: n = 15;
data pooled from three independent cultures; *p < 0.05, t test. Scale bars, 10 mm.
(D and E) Excitatory miniature events recorded from neurons biolistically transfected at 12 DIV with indicated constructs. Data are shown as mean ± SEM; GFP:
n = 12,Arhgap12: n = 16,Arhgap12_R695Q: n = 11,Arhgap12_D1–156aa: n = 11; data pooled from three independent experiments; *p < 0.05, **p < 0.01, one-way
ANOVA.
See also Figure S6.
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Figure 7. Disrupting ARHGAP12-CIP4 Interaction Impairs AMPAR Endocytosis
(A) HEK293T cells co-transfected with GFP-Arhgap12 and myc-Cip4 constructs were incubated with Pepctrl and PepARHGAP12-CIP4 with indicated concentrations
for 24 hr. Interaction between ARHGAP12 and CIP4 were examined using immunoblotting with an anti-ARHGAP12 antibody. n = 3.
(B) AMPAR endocytosis assay. (B1) Representative double-labeled images of the internalized (green) and surface (red) AMPAR GluA1 subunit in low-density
14 DIV hippocampal neurons. (B2) Ratiometric analysis of the intensity of internalized GluA1 to surface GluA1 in Pep
ctrl and PepARHGAP12-CIP4 conditions. Data are
shown as mean ± SEM; Pepctrl: n = 18, PepARHGAP12-CIP4: n = 19; data pooled from three independent cultures; *p < 0.05, t test. Scale bar, 10 mm.
(C) Excitatory miniature events recorded at 14 DIV from organotypic hippocampal slices treated with Pepctrl or PepARHGAP12-CIP4 for 24 hr. Data are shown as
mean ± SEM; Pepctrl: n = 13, PepARHGAP12-CIP4: n = 12; data pooled from three independent experiments; *p < 0.05, t test.
(D) Morphological analysis of dendritic spine density and volume of CA1 pyramidal neurons treated with 10 mM Pepctrl or 10 mM PepARHGAP12-CIP4 for 24 hr. Data
are shown as mean ± SEM; Pepctrl: n = 7, PepARHGAP12-CIP4: n = 7; data from three independent experiments; t test.
See also Figure S7.observed (Figure 7D). These results suggest that the
ARHGAP12-CIP4 interaction is responsible for controlling
AMPAR endocytosis but not for regulating spine morphology.
Together, our findings indicate that ARHGAP12 regulates
spine morphology via its GAP activity and synaptic strength via
its interaction with the F-BAR protein CIP4.1364 Cell Reports 14, 1355–1368, February 16, 2016 ª2016 The AuthDISCUSSION
The molecular mechanisms that promote excitatory synapse
formation and maturation have been extensively studied. How-
ever, themolecular events preventing precocious excitatory syn-
apse development so that synapses form at the correct time andors
place are less well understood. Here, we identified ARHGAP12,
a previously uncharacterized Rac1 GAP in the brain, as a critical
coordinator of synaptic structure and function in the developing
hippocampus.
ARHGAP12-Rac1 Signaling in Regulating Spine
Morphology
In the present study, we focused on hippocampal CA3-CA1 syn-
apses, based on the prominent expression of ARHGAP12 in CA1
during early development. We found that overexpressing WT
Arhgap12 resulted in reduced spine density and volume, and
an increased percentage of immature spines in CA1 pyramidal
neurons, whereas overexpressing the Arhgap12 GAP mutant
failed to generate a similar phenotype. In addition, we showed
that downregulation of Arhgap12 led to enlarged spine volume
and this enlargement was successfully rescued by pharmaco-
logically inhibiting overactive Rac1 signaling. These results
strongly suggest that negatively regulating Rac1 signaling via
ARHGAP12’s GAP activity is essential for maintaining the normal
dendritic spine structure at the CA3-CA1 synapse. These data
agreewith several other reports in which downregulation or over-
expression of Rac1 GAPs increased or decreased spine size and
density, respectively (Tolias et al., 2011). For instance, overex-
pression of the Rac1 GAP, alpha 1-chimerin, resulted in a loss
of spines by inhibiting the formation of new spines, as well as
promoting the pruning of existing spines (Buttery et al., 2006;
Van de Ven et al., 2005). More recently, mice lacking the Rac-
GAP Bcr and its relative Abr were shown to exhibit increased
spine size and density (Um et al., 2014).
An intriguing aspect of our study is that ARHGAP12 exhibits a
unique spatiotemporal profile, with almost exclusive expression
in CA1 and DG. Specific spatiotemporal profiles have been
observed for numerous GEFs and GAPs and are believed to
contribute to the specificity of Rho signaling in the brain (Tolias
et al., 2011). Our study thus unveils a vital role of ARHGAP12
in regulating spine structure via Rac1 signaling in CA1 and
supports the hypothesis that Rho GEFs and GAPs cooperate
in complementary signaling pathways to spatially and temporally
regulate Rho GTPase signaling during synapse remodeling
(Duman et al., 2015)
ARHGAP12-CIP4 Interaction in Regulating Synaptic
Strength
In this study, we found that knocking down Arhgap12 potenti-
ated hippocampal CA3-CA1 synapses, whereas Arhgap12
upregulation led to significant synaptic depression. Specifically,
Arhgap12 knockdown increased AMPAR-mediated EPSCs and
the frequency and amplitude of mEPSCs, indicating that
reducing ARHGAP12 levels promoted synaptic expression of
AMPARs. Due to the tight correlation between synaptic strength
and spine size, the increase in synaptic strength could occur as a
consequence of the changes in spine size (Matsuzaki et al.,
2001; Nimchinsky et al., 2002). Alternatively, ARHGAP12 could
regulate synapse function independently of spine size. We found
that the F-BAR-containing protein CIP4 interacts with
ARHGAP12. Similar to ARHGAP12, CIP4 is highly expressed
during early cortical development, and CIP4 inhibits neurite for-
mation by promoting lamellipodial protrusions (SaengsawangCell Ret al., 2012) and restrains synaptic growth at the NMJ (Nahm
et al., 2010). We demonstrated that the interaction between
ARHGAP12 and CIP4 involves the N terminus of ARHGAP12
and is independent of its GAP activity. CIP4 is recruited in cla-
thrin-coated pits during clathrin-mediated endocytosis (Shi-
mada et al., 2007), implying a function for CIP4 in this process.
We showed that interrupting the ARHGAP12-CIP4 interaction,
using a peptide mimicking the ARHGAP12 binding site on
CIP4, resulted in elevated AMPAR-mediated transmission. In
addition, interfering with the ARHGAP12-CIP4 interaction
decreased the endocytosis of GluA1 AMPAR subunits, leading
to more synaptic AMPARs. We found that the interaction be-
tween ARHGAP12 and CIP4 was not required for regulating
spine morphology. This is somewhat different from the function
of CIP4 at the NMJ inDrosophila, where dCIP4 acts downstream
of Cdc42 to activate the postsynaptic Wsp-Arp2/3 pathway and
thus restrain synaptic growth (Nahm et al., 2010). Together,
these data suggest that by binding to CIP4, ARHGAP12 in-
creases AMPAR endocytosis and thereby reduces synaptic
strength. Several studies have shown that events triggering
changes spine morphology and insertion or removal of AMPAR
subunits are distinct. How these two events are kept in check
so that changes in spine morphology correlate with synaptic
strength is still unclear. The GluA1 C-tail has been proposed to
play a critical role herein by linking both events (Kopec et al.,
2006). Our data unveil an interesting model in which ARHGAP12,
via its GAP activity, regulates spine structure, while by interact-
ing with CIP4, ARHGAP12 is able to modulate AMPAR-mediated
synaptic transmission in the hippocampus. Thus neurons might
use an elegantmechanism to keep changes in spinemorphology
and synaptic strength balanced, where ARHGAP12 signaling
controls both actin polymerization and AMPAR trafficking.
Exactly how ARHGAP12 and CIP4 cooperate to increase
AMPAR endocytosis remains to be elucidated. It is possible
that CIP4, similar to FBP17, affects AMPAR endocytosis by
recruiting Wiskott-Aldrich syndrome protein and dynamin for
vesicle initiation and scission (Shimada et al., 2007).
Synaptic Maturation Is Restricted by ARHGAP12 during
Hippocampal Development
A characteristic hallmark of the developing brain is the presence
of silent synapses, which contain NMDARs but lack AMPARs.
Premature or delayed synapse unsilencing has been implicated
in neurodevelopmental disorders, including ASD (Clement et al.,
2012, 2013; Sasaki et al., 2010). Because ARHGAP12 is highly
expressed during early postnatal stages and is followed by a
gradual decline in CA1, which mirrors the trend of robust synap-
togenesis, it raises the possibility that the presence of
ARHGAP12 might impede synaptic development. Our data
showed that the potentiation of synaptic transmission, as a result
of Arhgap12 downregulation, was the strongest at 4 DIV and
gradually decreased with age. Conversely, when ARHGAP12
was maintained at a high level, synaptic development was
impeded. We thus unveil a potentially interesting positive feed-
back mechanism between synaptic activity and ARHGAP12
signaling in the sense that synaptic activity is required for
ARHGAP12 repression and, in turn, ARHGAP12 down-
regulation enhances synaptic efficacy. Such a positive feedbackeports 14, 1355–1368, February 16, 2016 ª2016 The Authors 1365
relationship could play a key role during critical periods of syn-
apse development, with too little activity preventing synapse
development. Our data thus support the notion that ARHGAP12
is an intrinsic factor in the developmental program of synapses
and functions as a synaptic brake during hippocampal develop-
ment. Releasing the braking effect of ARHGAP12 at an inappro-
priate time might result in mistimed maturation of glutamatergic
synapses and in a disrupted balance between excitation and
inhibition in the hippocampus.
In addition, several genes associated with ASD have been
identified to function like synaptic brakes to prevent precocious
maturation of excitatory synapses. In particular, accelerated
maturation of excitatory synapses in an early period of hippo-
campal development has been observed in a mouse model of
human SYNGAP1 haploinsufficiency, leading to learning deficits
(Clement et al., 2012). Similarly, accelerated maturation of gluta-
matergic synapse has been seen in a knockout mouse model for
MET receptor tyrosine kinase. Hepatocyte growth factor (HGF)
signaling through MET receptor activation prevents the matura-
tion of silent synapses (Qiu et al., 2014). This is of particular
interest because ARHGAP12 was initially characterized as a
transcriptional target of HGF in epithelial cells (Gentile et al.,
2008). In addition, MET is highly expressed in CA1 pyramidal
neurons during late prenatal and early postnatal development
(Achim et al., 1997; Judson et al., 2009; Thewke and Seeds,
1999), similar to the expression pattern of ARHGAP12. This
raises the intriguing possibility that ARHGAP12 might function
downstream of MET signaling in the developing hippocampus.
Future experiments will have to determine whether and how
ARHGAP12 participates in MET signaling during development.
EXPERIMENTAL PROCEDURES
Virus production, western blot, immunofluorescence, yeast two-hybrid
screening, and image analysis are described in the Supplemental Experi-
mental Procedures.
Animals
Wistar rats were housed per two or three animals on a 12 hr light cycle in a tem-
perature-controlled (21 ± 1C) environment with ad libitum access to food and
water. Rats were used at E18 or postnatal day 6 (P6) for primary neuronal cul-
tures or organotypic hippocampal slices, respectively. All experiments
involving animals were evaluated and approved by the Committee for Animal
Experiments of the Radboud University Nijmegen Medical Centre, Nijmegen,
the Netherlands.
Electrophysiology
Whole-cell recordings in cultured slices were obtained with Multiclamp 700B
amplifiers (Axon Instruments). To study the effects of ARHGAP12 on synaptic
transmission, organotypic hippocampal slices were infected with lentiviruses
expressing shRNAs on the same day of plating and recorded at indicated
times after infection (4, 7, and 13–14 DIV). To overexpress ARHGAP12, orga-
notypic hippocampal slices were biolistically transfected at 5 DIV (for evoked
EPSCs) or 12 DIV (for mEPSCs) using a Helios Gene Gun (Bio-Rad) and
analyzed 2 days post-transfection. Whole-cell recordings were obtained
simultaneously from an infected and an adjacent uninfected neuron in the
CA1 region under visual guidance, using epifluorescence and transmitted light
illumination. See the Supplemental Experimental Procedures for details.
Two-Photon Laser Scanning Microscopy
Imaging was essentially performed as described previously (Nadif Kasri et al.,
2009).1366 Cell Reports 14, 1355–1368, February 16, 2016 ª2016 The AuthSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
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